{"schema_version":"secwatch.filing_event.v1","accession":"0001053706-23-000025","form_type":"8-K","ticker":"CRAI","cik":"0001053706","company_name":"CRA INTERNATIONAL, INC.","filed_at":"2023-11-02T23:59:59+00:00","discovered_at":"2026-05-14T18:03:28.054711+00:00","generated_at":"2026-06-08T23:14:08.605880+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.78,"calibrated_materiality_score":0.78,"confidence":"high","headline":"CRA Q3 revenue $147.6M (-0.6% YoY); net income down 27.6%; FY guidance cut","bullets":["GAAP EPS $1.21 vs $1.63 YoY; non-GAAP EPS $1.13 vs $1.45; utilization fell to 66% from 74%.","Full-year FY2023 revenue guidance lowered to $610-$620M from $625-$640M; non-GAAP EBITDA margin 10.3%-10.7% from 11.0%-11.7%.","CEO cited unexpected slowdown in new project originations and higher headcount as key drivers of the miss.","Forensic Services and Life Sciences practices delivered double-digit revenue growth; international revenue up 13.2% YoY.","Board raised quarterly cash dividend 17% to $0.42/share, payable Dec 8 to holders of record Nov 28."],"urls":{"canonical":"https://secwatch.observer/filing/0001053706-23-000025","json":"https://secwatch.observer/filing/0001053706-23-000025.json","markdown":"https://secwatch.observer/filing/0001053706-23-000025.md","text":"https://secwatch.observer/filing/0001053706-23-000025.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1053706/000105370623000025/0001053706-23-000025-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1053706/000105370623000025/crai-20231102.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-08T23:14:08.605880+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"9bead875dd8d28cac979bd60be3635417545125e","claim":"CRA INTERNATIONAL, INC. reported fiscal third quarter ended September 30, 2023 results: revenue $147.6 million, net income $8.6 million, EPS $1.21 per diluted share. Guidance lowered.","evidence_excerpt":"operations continued their strong performance by expanding 13.2% year over year.” Highlights for Third Quarter Fiscal 2023 • Revenue declined 0.6% year over year to $147.6 million. • Utilization was 66%, and quarter-end headcount increased 11.3% year over year. • Net income decreased 27.6% year over year to $8.6 million, or 5.8% of revenue, compared with","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1053706/000105370623000025/0001053706-23-000025-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"fiscal third quarter ended September 30, 2023"},{"label":"Revenue","value":"$147.6 million"},{"label":"Net income","value":"$8.6 million"},{"label":"EPS","value":"$1.21 per diluted share"},{"label":"Guidance","value":"lowered"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}